Nuvalent, Inc. · NASDAQ:NUVL
Balcom Alexandra sold 11,430 Nuvalent, Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 3, 2026
On Apr 1, 2026, Balcom Alexandra (Chief Financial Officer) sold 11,430 Nuvalent, Inc. shares at an average US$105.21 for US$1.2M under a trading plan, leaving 85,533 shares. Filed Apr 3, 2026 (Form 4).
- Sold
- 11,430 shares
- Price
- US$105.21 average (US$104.39 to US$106.18)
- Value
- US$1.2M
- Holding after
- 85,533 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Class A Common Stock | Option exercise | 11,430 | US$1.08 | 96,963 | Direct |
| Apr 1, 2026 | Class A Common Stock | Sale | 3,544 | US$104.39 | 93,419 | Direct |
| Apr 1, 2026 | Class A Common Stock | Sale | 5,417 | US$105.30 | 88,002 | Direct |
| Apr 1, 2026 | Class A Common Stock | Sale | 2,469 | US$106.18 | 85,533 | Direct |
Source
Related
- Nuvalent, Inc.
- Balcom Alexandra
- Nuvalent, Inc. shareholders
- Form 4 · Balcom Alexandra · Jul 15, 2026
- Form 4 · Balcom Alexandra · Jul 6, 2026
- Form 4 · Balcom Alexandra · Jun 3, 2026
- Form 4 · Balcom Alexandra · May 5, 2026
- Form 4 · Deerfield Private Design Fund IV, L.P. · Jul 17, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · Jul 17, 2026
- Form 4 · Meyers Michael L. · Jul 15, 2026
- Form 4 · Srivastava Sapna · Jul 15, 2026
- Form 4 · Oliger Christy J. · Jul 15, 2026